Castleark Management LLC Guardant Health, Inc. Transaction History

Castleark Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$109.77 - $165.68 $1.53 Million - $2.3 Million	-13,898 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$127.04 - $179.1 $1.2 Million - $1.7 Million	-9,470 Reduced 40.53%	13,898 $2.12 Million
Q4 2020 Feb 17, 2021	BUY	$99.96 - $135.93 $2.34 Million - $3.18 Million	23,368 New	23,368 $3.01 Million
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $4.67 Million - $6.49 Million	-78,420 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$62.59 - $110.3 $5.06 Million - $8.91 Million	-80,779 Reduced 50.74%	78,420 $5.01 Million
Q2 2019 Aug 13, 2019	BUY	$63.94 - $91.11 $10.2 Million - $14.5 Million	159,199 New	159,199 $13.7 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.